Literature DB >> 304839

The effect of protease inhibitors on leucocyte migration inhibition to tuberculin extract (P.P.D.).

A C Burden, R L Stacey, R F Wood, P R Bell.   

Abstract

The protease inhibitors, Epsilon Amino Caproic Acid (E.A.C.A.) and Aprotinin were found to significantly increase the inhibition produced by P.P.D. in the Leucocyte Migration Test (L.M.T.). Dose-response curves showed that the most effective concentrations were for E.A.C.A. 0.01 M and Aprotinin 100 I.U./ml. In a series of 29 subjects with a range of Heaf reactivity this finding was consistent providing that there was a significant inhibition to P.P.D. alone. At these concentrations, cell viability was unaffected and the effect of the drugs could be reversed by washing. The exact mode of action of these inhibitors in the L.M.T. requires further elucidation.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 304839      PMCID: PMC1457704     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  2 in total

1.  The effects of proteolysis on the human immune mechanism in cancer. A preliminary communication.

Authors:  R D Thornes; H Smyth; O Browne; M O'Gorman; D J Reen; D Farrell; P D Holland
Journal:  J Med       Date:  1974

2.  Human lymphocyte migration as a parameter of hypersensitivity.

Authors:  M Soborg; G Bendixen
Journal:  Acta Med Scand       Date:  1967-02
  2 in total
  3 in total

1.  The in vitro effect of aprotinin upon spleen cells from normal and tumour-bearing mice exposed to PPD and tumour cells.

Authors:  J G Freeman; A L Latner; G A Turner; C W Venables
Journal:  Experientia       Date:  1980-02-15

2.  Why do protease inhibitors enhance leucocyte migration inhibition to the antigen PPD?

Authors:  A C Burden; R Stacey; R F Wood; P R Bell
Journal:  Immunology       Date:  1978-12       Impact factor: 7.397

3.  TEEM-test studies on effect of aprotinin on in vitro response of cancer patients' lymphocytes to PPD.

Authors:  J G Freeman; A L Latner; B K Shenton; G A Turner; C W Venables
Journal:  Br J Cancer       Date:  1978-11       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.